Endo Pharmaceuticals Advances

Novell rises; Ameristar jumps; plus more of today's stocks in the news

The FDA granted final approval of Endo Pharmaceuticals' (ENDP ) application for pain drug oxycodone extended-release tablets, 10mg, 20mg, and 40mg.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.